Sign in
DRMA Stock Price, Chart, Stats & News
Dermata Therapeutics, Inc.
Save
Dermata Therapeutics, Inc. (DRMA) does not currently pay a dividend.
776,975
Market cap
–
Current P/E
–
Forward P/E
DRMA chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -96.12% |
ROE | -130.89% |
D/E | – |
Interest coverage ratio | – |
DRMA valuation
P/E | – |
P/S | – |
P/B | 0.23x |
P/CF | -0.19x |
P/FCF | -0.10x |
P/OCF | -0.19x |
PEG | -0.00x |
EV multiple | -1.10x |
About
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Similar securities
Based on sector and market capitalization
Report issue